Pharmaceutical solutions & Specialty ingredients

About SEQENS in 2022

Our main activities

A leader in
Pharmaceutical synthesis

A strong expertise in
Specialty Ingredients

A complete and integrated
R&D offer

Committed to developing
and sustainably producing

Newsroom

#Live

General / Press Release

Change in SEQENS’ shareholding structure

SEQENS is now stronger, more focused and positioned as one of the world’s leading players in pharmaceutical solutions and specialty ingredients 3 new…
Read more
General

Seqens becomes a partner of the RoLA-FLEX project

RoLA-FLEX is an industry-focused project that provides innovative solutions to the challenge associated with th performance and lifetime of Organic…
Read more
General

Seqens Prize of the French Académie des Sciences 2021

Congratulations to Alain Wagner, chemist, director of research at the CNRS – Centre national de la recherche scientifique, who…
Read more
See all news

Join the Seqens team!

Joining Seqens is a unique opportunity to participate in an exciting growth project with a strong international dimension and a strong entrepreneurial spirit.

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries